Carlyle One Health
'Protecting Society and Businesses from Infectious Diseases'
WHAT WE DO
"The trusted global resource for prevention, early-warning, and defense against airborne infectious disease pathogens."
Carlyle One Health has developed a groundbreaking portfolio of technology which enables the prevention, early warning, and rapid diagnosis of infectious disease viruses - protecting society, businesses and global supply chains.
​
Carlyle One Health products and services harness the power of CRISPR technology, advanced AI, learning algorithms, rapid cloud-based digital access to over 20,000 global data feeds, and a network of over 3,800 clinical specialists around the world.
​
THE FOUNDERS
Carlyle One Health was founded by Carlyle Global Partners, together with a group of accomplished family wealth-holders, an institutional investor and leading scientists including the Skoll Foundation, and the Ending Pandemics Academy.
​
Carlyle One Health's investors include Health2047. Founded by the American Medical Association ('AMA'), together with Health2047 Capital Partners, they fund and help build innovative healthcare companies. UnitedHealth Group ('United') is a strategic investor in Health2047 Capital Partners. United is a diversified healthcare company, which serves over
148 million customers in the United States.
OUR CAPABILITIES​
Advanced Capabilities: Carlyle One Health's proprietary technology enables unprecedented levels of prevention, early-warning and defense against airborne infectious diseases.​
​
WHO WE SERVE
​Our Clients: Carlyle One Health products and services enable prevention and early-warning of infectious disease outbreaks locally, and around the world, facilitating preemptive action by clinicians, business supply chain managers, owners and developers of the built-environment and national security specialists.​
For the Global South region, Carlyle One Health is also developing neglected tropical disease applications, designed especially for use in-the-field by community health workers, to assist in rapid, low-cost diagnosis and treatment selection.
Carlyle One Health
'Our Products and Services'
'Protecting Society and Businesses from Infectious Diseases.'
PRVENTION AND EARLY-WARNING​
-
Our cloud based, digital dashboard, accessed from a mobile device, enables prevention and early-warning of infectious disease outbreaks. Our technology platform is powered by rapid cloud-based digital access to over 20,000 global data feeds, a network of over 3,800 clinical specialists around the world and sophisticated AI capabilities.​
​​
-
In the built-environment, our groundbreaking CRISPR enabled technology, integrated with advanced AI, enables real-time monitoring of airborne viral load levels, and prevention of infectious diseases - providing essential protection for employees, customers, the general public and national security specialists in settings including offices, manufacturing facilities, arenas, airport terminals, residential settings, and hospitals.
​
RAPID DIAGNOSIS​
-
In the physicians office, point-of-care and community health settings, our AI enabled CRISPR technologies deliver rapid detection and early diagnosis of infectious diseases and viral pathogens, with unprecedented levels of accuracy, ease of use and low cost.​ CRISPR technology is regarded as one of the most important discoveries of the 21st century, with profound medical implications.
CARLYLE ONE HEALTH IQ
Co-hosted by leading institutions, Carlyle One Health IQ is our by-invitation series of video podcasts and in-person forums. Carlyle One Health IQ convenings are utilized by clients, leading innovators, accomplished scientists, global supply chain executives and investors to access knowledge, develop relationships with peers and advance their objectives in the prevention, early-warning and rapid diagnosis of infectious diseases.​​​​​
​​​
​​​
​​​
​​
​​
​​​​​​
​​